z-logo
open-access-imgOpen Access
Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile
Author(s) -
Michele D. Picard,
Jean-Luc Bodmer,
Todd M. Gierahn,
Alexander Lee,
Jessica Price,
Kenya Prince Cohane,
Veronica Clemens,
Victoria L. DeVault,
Galina Gurok,
Robert Kohberger,
Darren E. Higgins,
George R. Siber,
Jessica B. Flechtner,
William M. Geisler
Publication year - 2015
Publication title -
clinical and vaccine immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.649
H-Index - 77
eISSN - 1556-6811
pISSN - 1556-679X
DOI - 10.1128/cvi.00247-15
Subject(s) - chlamydia trachomatis , immunology , immune system , antigen , biology , pelvic inflammatory disease , tubal factor infertility , t cell , trachoma , cd8 , virology , medicine , infertility , pathology , pregnancy , genetics , gynecology
Chlamydia trachomatis is the causative agent of the most frequently reported bacterial sexually transmitted infection, the total burden of which is underestimated due to the asymptomatic nature of the infection. Untreated C. trachomatis infections can cause significant morbidities, including pelvic inflammatory disease and tubal factor infertility (TFI). The human immune response against C. trachomatis, an obligate intracellular bacterium, is poorly characterized but is thought to rely on cell-mediated immunity, with CD4(+) and CD8(+) T cells implicated in protection. In this report, we present immune profiling data of subjects enrolled in a multicenter study of C. trachomatis genital infection. CD4(+) and CD8(+) T cells from subjects grouped into disease-specific cohorts were screened using a C. trachomatis proteomic library to identify the antigen specificities of recall T cell responses after natural exposure by measuring interferon gamma (IFN-γ) levels. We identified specific T cell responses associated with the resolution of infection, including unique antigens identified in subjects who spontaneously cleared infection and different antigens associated with C. trachomatis-related sequelae, such as TFI. These data suggest that novel and unique C. trachomatis T cell antigens identified in individuals with effective immune responses can be considered as targets for vaccine development, and by excluding antigens associated with deleterious sequelae, immune-mediated pathologies may be circumvented.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom